Oxidized Proteome of Normal/Sideroblastic Erythroid Cell
Oxidized Proteome of Normal/Sideroblastic Erythroid Cell
批准号:
7591099
负责人:
JEFFREY S FRIEDMAN
金额:
$23.74万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-04-01 至 2011-03-31
关键词:
Affinity ChromatographyAgeAgingAmino AcidsAnemiaAvidinBiotinBuffersCell physiologyCellsCharacteristicsClinicalCoupledDevelopmentDiagnosticDiseaseErythrocytesErythroid CellsGelGoalsHumanImmunologicsInflammatoryInvestigationIonsIronLesionLocationMarrowMass Spectrum AnalysisMethodsModelingMusNeurodegenerative DisordersPathologicPathologyPatientsPatternPeptidesPost-Translational Protein ProcessingProteinsProteomeReagentRoleSOD2 geneSamplingSideroblastSideroblastic AnemiaSolidSpecimenTechniquesTestingTwo-Dimensional Gel ElectrophoresisValidationcomparativecyanine dyeimprovedmouse modelmulticatalytic endopeptidase complexnoveloxidationoxidative damageprognosticresponsesensor
中文摘要
描述(由申请人提供):我们建议表征具有特定类型的翻译后修饰蛋白羰基的蛋白质组的子集,其与多种病理学相关,包括炎症性疾病、神经退行性疾病、衰老和贫血。我们的目标是开发改进的试剂和技术,用于研究蛋白质羰基化在正常和病理状态下的细胞生理学中的作用。提高技术能力将有助于研究一些关于蛋白质氧化的基本问题:蛋白质氧化的层次是什么--是否有特定的蛋白质首先被羰基化,作为抗氧化损伤的缓冲剂?羰基化蛋白在蛋白酶体中易降解-“羰基传感器”蛋白的降解是否激活细胞对氧化损伤的反应?是否存在疾病特异性的蛋白质氧化的不同特征或模式?如果是这样,这些模式能否提供有用的诊断或预后信息?在这项提案中,我们将使用一个已建立的小鼠模型铁幼细胞贫血(SA),其中蛋白质羰基显着升高,作为基板的开发和验证的新技术的富集,定量和鉴定具有这种类型的氧化损伤的蛋白质。然后,我们将使用这些方法在分析纯化的铁粒幼细胞(铁负载细胞的特点,这种疾病)分离与SA患者的临床标本。我们提出了一种新的方法纯化这些铁负载细胞从患者样本,将促进这些研究。氧化蛋白的分析将采用亲和纯化、差异凝胶分析(DIGE)和质谱法来确定小鼠模型和临床标本中的氧化蛋白质组。
英文摘要
DESCRIPTION (provided by applicant): We propose to characterize that subset of the proteome possessing a particular type of post-translational modification protein carbonyls that has been associated with diverse pathologies including inflammatory conditions, neurodegenerative diseases, aging and anemia. Our goal is to develop improved reagents and techniques for study of the role of protein carbonylation in cellular physiology in both normal and pathologic states. Improved technical ability will facilitate investigation of a number of basic questions regarding protein oxidation: What is the hierarchy of protein oxidation -- are there specific proteins that are carbonylated first, which serve as a buffer against oxidative insult? Carbonylated proteins are subject to degradation in the proteasome --does degradation of `carbonyl sensor' proteins activate cellular responses to oxidative damage? Are there distinct signatures or patterns of protein oxidation that are disease specific? If so, can these patterns provide useful diagnostic or prognostic information? In this proposal we will use an established mouse model of Sideroblastic Anemia (SA), in which protein carbonyls are significantly elevated, as substrate for the development and validation of novel techniques for the enrichment, quantification and identification of proteins possessing this type of oxidative lesion. We will then use these methods in the analysis of purified sideroblasts (iron loaded cells characteristic of this disorder) isolated from clinical specimens of patients with SA. We present a novel method for purification of these iron loaded cells from patient samples that will facilitate these studies. Analysis of oxidized proteins will employ affinity purification, differential gel analysis (DIGE) and mass spectrometry to define the oxidized proteome in both the mouse model and clinical specimens.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.bcmd.2010.07.014
发表时间:
2010-10-15
期刊:
BLOOD CELLS MOLECULES AND DISEASES
影响因子:
2.3
作者:
[Xu, Xiuling, Martin, Florent, Friedman, Jeffrey S.]
通讯作者:
Friedman, Jeffrey S.
DOI:
10.3109/10715762.2012.756138
发表时间:
2013-03
期刊:
Free radical research
影响因子:
3.3
作者:
[Nagababu E, Mohanty JG, Friedman JS, Rifkind JM]
通讯作者:
Rifkind JM
Hemolytic Anemia: Biochemical, Molecular and Proteomic Diagnostics
-
批准号:7654467
-
项目类别:
-
资助金额:$47.48万
-
财政年份:2009
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
Hemolytic Anemia: Biochemical, Molecular and Proteomic Diagnostics
-
批准号:7934640
-
项目类别:
-
资助金额:$47.48万
-
财政年份:2009
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
Oxidized Proteome of Normal/Sideroblastic Erythroid Cell
-
批准号:7387295
-
项目类别:
-
资助金额:$27.96万
-
财政年份:2008
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
Anemia in the Elderly: Pathogenesis
-
批准号:7407984
-
项目类别:
-
资助金额:$38.07万
-
财政年份:2007
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
Anemia in the Elderly: Pathogenesis
-
批准号:7797541
-
项目类别:
-
资助金额:$37.78万
-
财政年份:2007
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
Reactive Oxygen Species in Anti-Viral Airway Host Defense
-
批准号:7497538
-
项目类别:
-
资助金额:$27.88万
-
财政年份:2007
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
DIGE Package: Variable Mode Imager and Spot Picker
-
批准号:7214952
-
项目类别:
-
资助金额:$21.51万
-
财政年份:2007
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
Anemia in the Elderly: Pathogenesis
-
批准号:7591119
-
项目类别:
-
资助金额:$38.07万
-
财政年份:2007
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
LEPTIN TREATMENT FOR PREVENTION OF THE METABOLIC AND ENDOCRINE SEQUELAE
-
批准号:7206993
-
项目类别:
-
资助金额:$69.99万
-
财政年份:2005
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
Pathogenesis and Therapy of Sideroblastic Anemia
-
批准号:6789691
-
项目类别:
-
资助金额:$20.27万
-
财政年份:2003
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
Pathogenesis and Therapy of Sideroblastic Anemia
-
批准号:6761972
-
项目类别:
-
资助金额:$4.22万
-
财政年份:2003
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
Pathogenesis and Therapy of Sideroblastic Anemia
-
批准号:6839428
-
项目类别:
-
资助金额:$33.6万
-
财政年份:2003
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
Pathogenesis and Therapy of Sideroblastic Anemia
-
批准号:6711204
-
项目类别:
-
资助金额:$33.6万
-
财政年份:2003
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
Pathogenesis and Therapy of Sideroblastic Anemia
-
批准号:7008475
-
项目类别:
-
资助金额:$32.81万
-
财政年份:2003
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
Leptin Treatment for Prevention of Metabolic & Endocrine
-
批准号:7041485
-
项目类别:
-
资助金额:$76.1万
-
财政年份:2003
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
Pathogenesis and Therapy of Sideroblastic Anemia
-
批准号:6612104
-
项目类别:
-
资助金额:$6.93万
-
财政年份:2003
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
Pathogenesis and Therapy of Sideroblastic Anemia
-
批准号:7175400
-
项目类别:
-
资助金额:$31.86万
-
财政年份:2003
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
CYCLOPHILIN C FUNCTION
-
批准号:2386364
-
项目类别:
-
资助金额:$8.16万
-
财政年份:1997
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
CYCLOPHILIN C FUNCTION
-
批准号:6388426
-
项目类别:
-
资助金额:$11.59万
-
财政年份:1997
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
CYCLOPHILIN C FUNCTION
-
批准号:6043686
-
项目类别:
-
资助金额:$11.59万
-
财政年份:1997
-
负责人:JEFFREY S FRIEDMAN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: